Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) According to the COVID-19 diagnosis and treatment protocol (trial Seventh Edition), the patient was diagnosed as a critically ill patient of COVID-19 (severe / critical group); (2) The patient signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) the subjects did not follow the research scheme and had poor compliance; (2) the subjects voluntarily asked to withdraw; (3) the researchers believe that there are other situations in which the subjects are not suitable to participate in this study; (4) the researchers assessed that the subjects in the trial group had contraindications for pulmonary rehabilitation, such as: 1) patients with myocardial infarction and shock in recent 3 months; 2) patients with severe cardiac instability and angina pectoris in recent 4 weeks; 3) massive hemoptysis in recent 4 weeks; 4) epileptic seizures need to be treated with drugs; 5) patients with uncontrolled hypertension (systolic blood pressure > 200mmHg, diastolic blood pressure > 100mmHg); 6) patients with aortic aneurysm; 7) severe hyperthyroidism; 8) Heart rate > 120 beats / min; 9) pneumothorax, giant pulmonary vesicles and not ready for surgical treatment; 10) pregnant women; 11) patients with tympanic membrane perforation; 12) recent respiratory tract infection (< 4 weeks); 13) those with low immunity. Patients with respiratory infectious diseases (such as tuberculosis, influenza); 14) the researchers believe that there are other conditions in which patients are not suitable for respiratory rehabilitation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life (SGRQ);MFI; | — |
Secondary
| Measure | Time frame |
|---|---|
| Activity ability (6-minute walking distance);HAMA& HAMD;Utilization rate of medical resources; | — |
Countries
China
Contacts
China-Japan Friendship Hospital